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Toward a Better Understanding of...

Nicotinamide as a Neuroprotective Agent
in Mouse Models with Delayed Hypoxemia
Following TBI
Alan Makedon
Mentor: Stuart Friess
Traumatic brain injury (TBI) is one of the leading causes of death and disability in children.
Despite advances in care, morbidity following TBI remains high. Following the initial
primary injury, critical secondary injuries develop from multiple mechanisms including
hypoxemia, ischemia, hypoglycemia, and excitotoxicity. Treatment of secondary injuries
to TBI patients provides a unique opportunity for therapeutic interventions and to
overcome the narrow temporal window of efficacy of many therapeutics. Nicotinamide
has been shown to provide neuroprotection when administered early after TBI in animal
models. The hypothesis of this ongoing study is that NAD treatment before delayed
hypoxemia in mice with TBI would reduce axonal injury and neuronal death. Twenty
8-week-old C57/B6 male mice underwent controlled cortical impact (CCI). Twenty-four
hours following CCI, the mice were subjected to 60 minutes of hypoxemia (8% FiO2)
treatment. Mice were randomly assigned to receive nicotinamide 500 mg/kg IP or an
equivalent volume of saline 2 hours before hypoxemia. Mice were sacrificed 24 hour after
hypoxemia. The brains of the mice were extracted and sectioned into 50 µm slices to be
used for immunohistochemistry. We stained the slices for beta amyloid precursor protein
(β-APP), NF200, and 4-HNE. Previous studies have suggested that these biomarkers are
highly expressed short term following TBI. We also stained the slices with Fluoro-Jade
C. Anterior white matter sections of the corpus callosum were analyzed with ImageJ
and the Fluoro-Jade slides were scanned with a confocal. We found little distinguishable
change between treatment/vehicle groups for βAPP and NF200 staining. However, our
ImageJ protocol has not been correlated with stereology, the current gold standard for
quantification. The remaining stains are still in progress of analysis. Furthermore, we
began testing a second cohort with longer-term survival to analyze neuronal death.
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